UNEEG EpiSight solution
DeviceImplantation subcutis under local anesthetics
NCT Number: NCT05915988
The present study is a 13 months pre-market open-label, prospective study for confirmation of continuous performance and safety of UNEEG EpiSight solution in subjects with uncontrolled epilepsy (indicated for EEG monitoring with the Implant) in which seizures are detectable in an area of the Implant. The surgical procedure, device satisfaction, and effectiveness of the UNEEG EpiSight solution will also be evaluated during the clinical investigation.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Aalborg University Hospital, Aalborg, Denmark
The study is a multi-center study with 2-5 European sites in 2-4 countries. Each site will enrol up to 10 subjects, but total enrolment will not exceed 22 to reach 19 completers of 40 days of recording. The total recruitment period is expected to be 6 months and the total study duration is expected to be approximate 22 months (first subject first visit to last subject out).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation subcutis under local anesthetics
Time frame: Throughout the run of the investigation (enrollment per subject is up to 12 months)
Number of recording hours by UNEEG EpiSight Recorder per day (24 hours) after 40 days recording
Time frame: Throughout the run of the investigation (enrollment per subject is up to 12 months)
Nature and frequency of device deficiencies
Time frame: Throughout the run of the investigation (enrollment per subject is up to 12 months)
Nature and frequency of adverse events
Time frame: Throughout the run of the investigation (enrollment per subject is up to 12 months)
Number of recording hours by UNEEG EpiSight solution per day (24 hours) throughout the study period
UNEEG Medical A/S
Industry
Wireless Ultra Long-Term EEG Recordings in Epilepsy - A Prospective Long-term Clinical Evaluation Using the UNEEG EpiSight Solution
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05954182
Brain Diseases, Central Nervous System Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT07717632
Brain Diseases, Central Nervous System Diseases
London, United Kingdom
View Trial DetailsNCT05439655
Brain Diseases, Central Nervous System Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT07676539
Activities, Daily Living, Behavior
Cincinnati, Ohio, United States
View Trial Details